Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
05/03/2011 | US7935357 Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species |
05/03/2011 | US7935353 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
05/03/2011 | US7935349 CRMP4b inhibitory peptide |
05/03/2011 | US7935347 DNA molecule corresponding to a nucleotide sequence of a cereal pollen major allergen; therapy of pollen-allergy diseases |
05/03/2011 | US7935333 Vaccine against brain protein; antiepileptic agents |
05/03/2011 | CA2581001C Kunitz-type recombinant inhibitor |
05/03/2011 | CA2518219C Igf-binding protein-derived peptide or small molecule |
05/03/2011 | CA2499430C Chicken astrovirus type 2 |
05/03/2011 | CA2469815C Methods for purifying protein |
05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
05/03/2011 | CA2451517C Defensin polynucleotides and methods of use |
05/03/2011 | CA2378586C Replication-competent anti-cancer vectors |
05/03/2011 | CA2376600C Porcine circovirus recombinant poxvirus vaccine |
05/03/2011 | CA2373026C Viral expression vectors |
05/03/2011 | CA2350776C Novel mitogenic regulators |
05/03/2011 | CA2347066C Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof |
05/03/2011 | CA2342966C Gene alteration in the gene for the gbeta3 subunit of the human g protein |
05/03/2011 | CA2293805C Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
05/03/2011 | CA2283680C Calcium phosphopeptide complexes |
05/03/2011 | CA2260761C Vaccine comprising antigens bound to carriers through labile bonds |
05/03/2011 | CA2246297C Use of an anti-human tnf-alpha monoclonal antibody in the manufacture of a therapeutic formulation for treating a thrombotic disorder |
05/03/2011 | CA2233207C Type cc chemokine-like protein |
05/03/2011 | CA2206509C Novel hedgehog-derived polypeptides |
04/29/2011 | CA2741418A1 Detection and modulation of cytochrome c acetylation |
04/28/2011 | WO2011050328A2 Assessment of solid tumor burden |
04/28/2011 | WO2011050311A1 Use of endostatin peptides for the treatment of fibrosis |
04/28/2011 | WO2011049914A2 Anti-hiv peptides and methods of use thereof |
04/28/2011 | WO2011049560A1 Glutamate receptors in nutrient sensing, metabolism, growth and development |
04/28/2011 | WO2011049350A9 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
04/28/2011 | WO2011049350A2 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
04/28/2011 | WO2011049043A1 Screening method utilizing thalidomide-targeting factor |
04/28/2011 | WO2011048614A2 Short chain peptidomimetics based orally active glp-1 agonist and glucagon receptor antagonist |
04/28/2011 | WO2011048602A1 Compounds restoring pancreatic beta cells |
04/28/2011 | WO2011048566A1 A means for inducing apomixis in cultivated plants having sexual reproduction and use thereof for the production of completely or partially apomictic plants |
04/28/2011 | WO2011048542A1 Peptides having the properties of a selective antagonist of alpha2 adrenergic receptors and uses thereof |
04/28/2011 | WO2011048503A2 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
04/28/2011 | WO2011048445A1 Inhibitors of guanine exchange factors and their use as anticancer drugs |
04/28/2011 | WO2011048248A1 Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof |
04/28/2011 | WO2011048215A1 Detection of a circovirus in calves suffering from bovine neonatal pancytopenia |
04/28/2011 | WO2011048029A1 Cyclic peptide synthesis |
04/28/2011 | WO2011026122A3 B7-h4 fusion proteins and methods of use thereof |
04/28/2011 | WO2011017492A3 Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants |
04/28/2011 | WO2011013034A4 Antigenic tau peptides and uses thereof |
04/28/2011 | WO2011008974A3 Rsv f protein compositions and methods for making same |
04/28/2011 | WO2011006966A9 Fermentation of moderately thermophilic bacilli on sucrose |
04/28/2011 | WO2010138885A3 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses |
04/28/2011 | WO2010135674A3 Methyl butenol synthase |
04/28/2011 | WO2010129895A3 Cd133 epitopes |
04/28/2011 | WO2010039652A3 Peptide toxin formulation |
04/28/2011 | WO2009134681A3 Adeno associated viral vectors for targeted transduction of retinal pigment epithetial cells |
04/28/2011 | WO2009060316A3 Hepatitis b virus-binding polypeptides and methods of use thereof |
04/28/2011 | WO2008070943A3 Soluble dimerized or oligomerized endostatin |
04/28/2011 | US20110099655 Transgenic Plants |
04/28/2011 | US20110099646 Green fluorescent protein optimized for expression with self-cleaving polypeptides |
04/28/2011 | US20110098452 Purification of modified cytokines |
04/28/2011 | US20110098451 Peptide-polymer conjugates |
04/28/2011 | US20110098447 Homogenous Populations of Molecules |
04/28/2011 | US20110098443 Anti-GLP-1R Antibodies and Their Uses |
04/28/2011 | US20110098442 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
04/28/2011 | US20110098440 Insulin Analogues with an Acyl and Alkylene Glycol Moiety |
04/28/2011 | US20110098439 Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids |
04/28/2011 | US20110098294 Purine analogs |
04/28/2011 | US20110098227 Soluble notch-based substrates for gamma secretase and methods and compositions for using same |
04/28/2011 | US20110098226 Small molecular weight TNF receptor multimeric molecule |
04/28/2011 | US20110098224 Protein kinase c peptide modulators of angiogenesis |
04/28/2011 | US20110098222 Glucagon-like-peptide-2 (glp-2) analogues |
04/28/2011 | US20110098218 Modulators of stat3 signalling |
04/28/2011 | US20110098217 Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
04/28/2011 | US20110098215 Peptides and methods of use as therapeutics and screening agents |
04/28/2011 | US20110098212 Cytokine |
04/28/2011 | US20110098211 Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same |
04/28/2011 | US20110098207 Cellulase-Free Enzyme Compositions and Host Cells for Producing the Same |
04/28/2011 | US20110098191 In vitro methods for detecting renal cancer |
04/28/2011 | US20110098183 Plants with increased yield and/or increased tolerance to environmental stress (iy-bm) |
04/28/2011 | US20110097794 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
04/28/2011 | US20110097783 Proteases from gram-positive organisms |
04/28/2011 | US20110097771 Isolated polynucleotides and polypeptides and methods of using same for increasing plant utility |
04/28/2011 | US20110097749 Process for producing hepcidin |
04/28/2011 | US20110097747 Monoclonal antibody binds antigen associated with human tumors |
04/28/2011 | US20110097742 Contrast agents, methods for preparing contrast agents, and methods of imaging |
04/28/2011 | US20110097741 Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays |
04/28/2011 | US20110097737 Methods and Compositions for Targeting Proteins of Interest to the Host Cell Envelope |
04/28/2011 | US20110097726 Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
04/28/2011 | US20110097709 Method for modifying a nucleic acid |
04/28/2011 | US20110097708 Assessment of human papilloma virus-related disease |
04/28/2011 | US20110097362 Transmucosal Administration of Aggregated Antigens |
04/28/2011 | US20110097360 Streptococcus pneumoniae pilus antigens |
04/28/2011 | US20110097359 Production of diphtheria toxin |
04/28/2011 | US20110097357 Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells |
04/28/2011 | US20110097353 Poultry viral materials and methods related thereto |
04/28/2011 | US20110097348 Protein Formulation |
04/28/2011 | US20110097340 Fully human anti-vegf antibodies and methods of using |
04/28/2011 | US20110097334 Novel Marker Genes for Regulatory T Cells from Human Blood |
04/28/2011 | US20110097333 Therapeutic and diagnostic agents |
04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
04/28/2011 | US20110097324 Compositions and methods for modulating nicotinic/nmda receptor function |
04/28/2011 | US20110097309 Pharmaceutical Agent for Promoting the Functional Regeneration of Damaged Tissue |
04/28/2011 | US20110097276 Diagnosis of Prostate Cancer |
04/28/2011 | DE112009000313T5 Pflanzen mit erhöhtem Ertrag Plants with increased yield |
04/28/2011 | CA2778533A1 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |